SNT 0.00% 3.8¢ syntara limited

price is creeping up

  1. 766 Posts.
    lightbulb Created with Sketch. 163
    Looks like the price is creeping up again.

    Phase 3 CF trial results due out within next 3 months.

    Positive result shoudl allowing marketing applications in Aust & Europe.

    Market size Aust&Europe 45,000 patients

    Potential take up 20% = 9,000 patients

    Revenue per patient approx $13,000 (est by PXS on investor calls)

    Revenue per annum potential $117m

    This does not include potential US sales later
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.000(0.00%)
Mkt cap ! $45.37M
Open High Low Value Volume
3.8¢ 3.8¢ 3.8¢ $959 25.22K

Buyers (Bids)

No. Vol. Price($)
6 367244 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 636815 2
View Market Depth
Last trade - 13.12pm 25/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.